Skip to content
Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes? episode artwork

EPISODE · Nov 17, 2022 · 37 MIN

Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

from PeerVoice Clinical Pharmacology Video · host PeerVoice

Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

Episode metadata supplied by the publisher feed · Published Nov 17, 2022

Embed this episode

Visit https://www.peervoice.com/NHW860 to view the entire programme with slides. After completing “Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?”, participants will be able to: Summarise the latest clinical data on adjuvant immunotherapy for resected melanoma; Describe the strengths and limitations of this evidence within the context of current clinical practice in the adjuvant treatment of resected melanoma; and Identify patients with resected melanoma who are at risk of recurrence.

Distinct summary based on available episode metadata or transcript content.

Ready to play

Paolo Antonio Ascierto, MD - Emerging Data on Adjuvant Immunotherapy for Resected Melanoma: What Changes?

0:00 37:54

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

Frequently Asked Questions

How long is this episode of PeerVoice Clinical Pharmacology Video?

This episode is 37 minutes long.

When was this PeerVoice Clinical Pharmacology Video episode published?

This episode was published on November 17, 2022.

Can I download this PeerVoice Clinical Pharmacology Video episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!